Population: General population

Individuals who do not belong to a defined subgroup with specific characteristics, representing the broader population

Maglione

Italy
|
2023-2025
  • General population
  • Infants (<1 year)
  • Hospital
  • SARS-CoV-2
  • Respiratory syncytial virus
  • Influenza virus
  • Respiratory syncytial virus infection
  • Influenza
  • COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • Nirsevimab

Vera-Punzano

Spain
|
2023-2024
  • General population
  • Infants (<1 year)
  • Hospital
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection
  • Pharmacological intervention
  • Monoclonal antibodies
  • Nirsevimab

Barbas Del Buey

Spain
|
2023-2024
  • General population
  • Infants (<1 year)
  • Community
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection
  • Pharmacological intervention
  • Monoclonal antibodies
  • Nirsevimab

Savino

Italy
|
2023-2024
  • General population
  • Infants (<1 year)
  • Hospital
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection

Korkmaz

Türkiye
|
2022-2023
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Hospital
  • Emergency department
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection

Ferrari

Italy
|
2022-2023
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Hospital
  • Emergency department
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection

Ehlmaier

Austria
|
2021-2022
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Primary care
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection

Chitgupi

Colombia Finland Ghana Honduras India Spain Thailand United States
|
2023-2024
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Primary care
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection

TwinSeVeRS

France
|
2021-2022
  • General population
  • Infants (<1 year)
  • Hospital
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection

ARF-RSV

France
|
2023-2026
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Intensive care unit
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection
  • Blood sample

Oursyn

France
|
2021-2024
  • General population
  • Infants (<1 year)
  • Outpatient clinic
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection

IRIS

Germany
|
2013-2023
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Hospital
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection
  • Blood sample
  • Nasopharyngeal swab
  • Nasal lining fluid sample